Kemp Proteins’ Quality Management System receives ISO13485:2016 Certification
Frederick, Maryland, April 12, 2022 — Kemp Proteins, a leading provider of gene-to-protein and monoclonal antibody development services to the pharmaceutical, diagnostics, and research industries, announced today that it has received ISO 13485:2016 certification for its Quality Management System (QMS). Achieving ISO 9001:2015 (certified since 2020) and now ISO 13485 certification demonstrates Kemp’s commitment to a company culture of continuous improvement and risk-based decision making, focused on providing our client partners with world-class protein development and manufacturing services. ...